Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Disc Medicine, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- −5 vs. Q4 2021
- Shares held
- 28.5M
- −3.76M (−11.7%) vs. Q4 2021
- Total value
- $39.6M
- −$54.2M (−57.8%) vs. Q4 2021
- New holders
- 8
- 13 more added
- Sold out
- 13
- 23 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ulland Investment Advisors, LLC | 348 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 200 | $0 | 0.00% | +200 | New |
| Citigroup Inc | 918 | $1.00K | 0.00% | −4,661−83.5% | Reduced |
| Royal Bank of Canada | 1,572 | $2.00K | 0.00% | −3,301−67.7% | Reduced |
| Ameritas Investment Partners, Inc. | 1,718 | $2.00K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 1,201 | $2.00K | 0.00% | −14−1.2% | Reduced |
| Legal & General Group Plc | 2,432 | $3.00K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,897 | $4.00K | 0.00% | +2,897 | New |
| Amalgamated Financial Corp. | 2,897 | $4.00K | 0.00% | +2,897 | New |
| Barclays PLC | 3,559 | $5.00K | 0.00% | +3,559 | New |
| STRS Ohio | 5,100 | $7.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,141 | $10.0K | 0.00% | −13,620−65.6% | Reduced |
| Tower Research Capital LLC (TRC) | 8,368 | $12.0K | 0.00% | −14,467−63.4% | Reduced |
| California State Teachers Retirement System | 9,679 | $13.0K | 0.00% | −1,201−11.0% | Reduced |
| Penserra Capital Management LLC | 9,974 | $13.0K | 0.00% | +1,490+17.6% | Added |
| Walleye Trading LLC | 10,301 | $14.0K | 0.00% | −4,379−29.8% | Reduced |
| JPMorgan Chase & Co | 10,274 | $14.0K | 0.00% | −278−2.6% | Reduced |
| Gyon Technologies Capital Management, LP | 10,200 | $14.0K | 0.01% | +10,200 | New |
| Running Point Capital Advisors, LLC | 10,000 | $14.0K | 0.01% | +10,000 | New |
| American International Group, Inc. | 10,875 | $15.0K | 0.00% | −766−6.6% | Reduced |
| Deutsche Bank AG | 11,893 | $17.0K | 0.00% | −42,631−78.2% | Reduced |
| Walleye Capital LLC | 15,226 | $21.0K | 0.00% | −10,753−41.4% | Reduced |
| Susquehanna International Group, LLP | 16,633 | $23.0K | 0.00% | −29,522−64.0% | Reduced |
| Rhumbline Advisers | 17,304 | $24.0K | 0.00% | −1,434−7.7% | Reduced |
| Goldman Sachs Group Inc | 20,338 | $28.0K | 0.00% | −52,440−72.1% | Reduced |
| Morgan Stanley | 30,952 | $42.0K | 0.00% | +6,502+26.6% | Added |
| Prelude Capital Management, LLC | 31,163 | $43.0K | 0.00% | −1,637−5.0% | Reduced |
| Boothbay Fund Management, LLC | 42,297 | $59.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 46,453 | $65.0K | 0.00% | −11,283−19.5% | Reduced |
| Wells Fargo & Company | 47,703 | $66.0K | 0.00% | +27,349+134.4% | Added |
| Crestline Management, LP | 62,500 | $87.0K | 0.01% | +62,500 | New |
| Marquette Asset Management, LLC | 66,269 | $92.0K | 0.02% | +66,269 | New |
| Bank of New York Mellon Corp | 69,078 | $96.0K | 0.00% | −1,659−2.3% | Reduced |
| Nuveen Asset Management, LLC | 80,679 | $116.0K | 0.00% | +3,449+4.5% | Added |
| Stifel Financial Corp | 103,821 | $144.0K | 0.00% | +37,921+57.5% | Added |
| Allspring Global Investments Holdings, LLC | 115,213 | $160.0K | 0.00% | +98,956+608.7% | Added |
| Bridgeway Capital Management, LLC | 117,500 | $163.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 195,340 | $272.0K | 0.00% | −5,663−2.8% | Reduced |
| Harvard Management Co Inc | 250,000 | $348.0K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 341,410 | $474.0K | 0.00% | +6,154+1.8% | Added |
| Renaissance Technologies LLC | 351,100 | $488.0K | 0.00% | +339,200+2,850.4% | Added |
| FMR LLC | 397,346 | $551.0K | 0.00% | −1,489,895−78.9% | Reduced |
| State Street Corp | 408,704 | $568.0K | 0.00% | −3,511−0.9% | Reduced |
| Geode Capital Management, LLC | 431,325 | $599.0K | 0.00% | −11,642−2.6% | Reduced |
| Ikarian Capital, LLC | 443,096 | $615.0K | 0.19% | +22,046+5.2% | Added |
| Pura Vida Investments, LLC | 496,120 | $690.0K | 0.08% | +3,100+0.6% | Added |
| Millennium Management LLC | 536,202 | $745.0K | 0.00% | +28,874+5.7% | Added |
| Vanguard Group Inc | 740,803 | $1.03M | 0.00% | −327,853−30.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 882,612 | $1.23M | 0.00% | +200,000+29.3% | Added |
| Franklin Resources Inc | 1,071,790 | $1.49M | 0.00% | −1,440,983−57.3% | Reduced |
| Boxer Capital, LLC | 1,300,000 | $1.81M | 0.09% | 00.0% | Unchanged |
| BlackRock Inc. | 1,300,204 | $1.81M | 0.00% | +43,831+3.5% | Added |
| Suvretta Capital Management, LLC | 2,372,267 | $3.30M | 0.10% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 2,435,125 | $3.38M | 1.38% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 2,435,125 | $3.38M | 4.74% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,254,365 | $7.30M | 0.92% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,826,224 | $8.10M | 0.13% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −635,692−100.0% | Sold out |
| JS Capital Management LLC | 0 | $0 | 0.00% | −474,457−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −43,275−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,349−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −19,273−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −15,421−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,829−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −12,654−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,013−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −332−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −37−100.0% | Sold out |